Heart valve allograft decontamination with antibiotics: Impact of the temperature of incubation on efficacy

Cell and Tissue Banking

Volumn 11, Issue 2, 2010, Pages 197-204

  Germain, Marc ^a   Thibault, Louis ^a   Jacques, Annie ^a   Tremblay, Jacynthe ^a   Bourgeois, Rémi ^a  

^a HÉMA QUÉBEC   (Canada)

Author keywords

Bacterial contamination; Disinfection; Homograft; Valvular

Indexed keywords

ANTIINFECTIVE AGENT; CEFOXITIN; GENTAMICIN; VANCOMYCIN;

ALLOTRANSPLANTATION; CONFERENCE PAPER; DISINFECTION; HEART VALVE; HUMAN; METHODOLOGY; MICROBIOLOGY; TEMPERATURE; TRANSPLANTATION;

ANTI-BACTERIAL AGENTS; CEFOXITIN; DISINFECTION; GENTAMICINS; HEART VALVES; HUMANS; TEMPERATURE; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTS; VANCOMYCIN;

EID: 77953538124     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10561-009-9155-y     Document Type: Conference Paper

References (12)

1. Angell JD, Christopher BS, Hawtrey O, Angell WM (1976) A fresh, viable human heart valve bank: sterilization, sterility testing, and cryogenic preservation. Transplant Proc 8:139-147
2. Barratt-Boyes BG, Roche AH, Subramanyan R, Pemberton JR, Whitlock RM (1987) Long-term follow-up of patients with the antibiotic-sterilized aortic homograft valve inserted freehand in the aortic position. Circulation 75:768-777
3. Gall K, Smith S, Willmette C, Wong M, O'Brien M (1995) Allograft heart valve sterilization: a six-year in-depth analysis of a twenty-five-year experience with low-dose antibiotics. J Thorac Cardiovasc Surg 110:680-687
4. Ireland L, Spelman D (2005) Bacterial contamination of tissue allografts-experiences of the donor tissue bank of Victoria. Cell Tissue Bank 6:181-189
5. Jashari R, Tabaku M, Van Hoeck B, Cochez C, Callant M, Vanderkelen A (2007) Decontamination of heart valve and arterial allografts in the European Homograft Bank (EHB): comparison of two different antibiotic cocktails in low temperature conditions. Cell Tissue Bank 8:247-255
6. Kirklin JW, Blackstone EH, Maehara T, Pacifico AD, Kirklin JK, Pollock S, Stewart RW (1987) Intermediate-term fate of cryopreserved allograft and xenograft valved conduits. Ann Thorac Surg 44:598-606
7. Kuehnert MJ, Clark E, Lockart SR, Soll DR, Chia J, Jarvis WR (1998) Candida albicans endocarditis associated with a contaminated aortic valve allograft: implications for regulation of allograft processing. Clin Infect Dis 27:688-691
8. Meyer SR, Nagendran J, Desai LS, Rayat GR, Churchill TA, Anderson CC, Rajotte RV, Lakey JR, Ross DB (2005) Decellularization reduces the immune response to aortic valve allografts in the rat. J Thorac Cardiovasc Surg 130:469-476
9. Parker R (1997) An international survey of allograft banks. In: Yacoub MH (ed) Cardiac valve allograft. Science and practice. Springer, New York, pp 5-9
10. Stolinski J, Marek G, Marcinkowska Z, Jaskier M, Barecka D, Bartus K, Kapelak B, Sadowski J, Dziatkowiak A (2006) Allogenic heart valve bank in the Department of Cardiovascular Surgery and Transplantology of Jagiellonian University in Cracow-23 years experience in the treatment of aortic valve or aortic root diseases. Cell Tissue Bank 7:175-182
11. Strickett MG, Barratt-Boyes BG, MacCulloch D (1983) Disinfection of human heart valve allografts with antibiotics in low concentration. Pathology 15:457-462
12. Yacoub M, Kittle CF (1970) Sterilization of valve homografts by antibiotic solutions. Circulation 41: II29-II32